| |
Focus On
Mission to Stop a Devastating
Disease
Friedreich’s ataxia is a rare, genetic, life-shortening
disorder. Its symptoms, which can begin as early as age five,
include muscle weakness and loss of coordination in the arms
and legs; vision impairment, hearing loss, and slurred speech;
curvature of the spine; diabetes mellitus or carbohydrate
intolerance; and a serious heart condition (hypertrophic
cardiomyopathy).
Right now, there is no treatment or cure to
Friedreich’s ataxia. But today, there is hope thanks to Dr.
Joel Gottesfeld, a dedicated scientist at Scripps
Research.
Learn how
Dr. Gottesfeld is leading his
team to find a small molecule
that could be developed into a pharmaceutical to fix the gene
mutation responsible for this debilitating
disease.
Milestones in Medical Science
The Big Picture: Nicholas Schork
Searches the Genetic Code for Clues
Nicholas Schork was working on a graduate degree in
philosophy at the University of Michigan when he got a
job at the nearby medical school writing programs to
analyze medical data. While there, he came into contact with
some of the scientists who would ultimately prove to be
pioneers in genetics research. Their work changed his life.
Now, as a professor in the Department of Molecular and
Experimental Medicine at Scripps Research, and the director of
research for genomic medicine at Scripps Health, Dr. Schork is
working to bridge the gap between producing useful information
about the human genome, and using it to develop
life-saving treatments for cancer and other diseases.
The Future of Scripps
Marjorie Fink looks
forward, not back
On September 11, 2001 as the whole world was focused on
the destruction of the World Trade Center, Rodney and Marjorie
Fink discovered terrible news of their own. On that day they
learned that Rodney had non-smoker’s lung cancer. This
devastating disease is one of the most lethal cancers known.
He lived barely three months after the diagnosis.
After Mr. Fink’s illness and death, his wife Marjorie’s
interest in medical research was captured by the announcement
of the Scripps Florida project. She has become a pivotal
figure in the development of Scripps Florida, and a
motivating force behind our pioneering science.
|
|
| Facts & Figures |
| Scripps Research scientists have
identified a possible drug target for slowing
progression of Parkinson's
disease. |
Own a Piece of Medical
History
At Scripps Research, we provide the
spark that fuels medical innovation. And with your help,
we will continue to find the answers that lead to
treatments and cures for today's deadliest
diseases.
Own a piece of medical history,
support Scripps Research.
|
| Share this with a
friend |
|
Outreach
A Bequest to Fight Disease – A Life Long
Gift How
do you make a meaningful gift, providing the greatest
benefit for you and Scripps
Research?
The
answer is planned
giving.
The Legacy Society
Luncheon Our annual luncheon will honor
those who have made bequests and other planned
gifts. Learn
more.
May Lab
Notes Featured in At the Forefront, come
meet Dr.
Steven Mayfield in
person!
| |